Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.

PLoS One · 2013 · PMC3812039 · PMID 24205279

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

borderline non-significantp=0.09so close (0.05 < p ≤ 0.1)

In the current study, FGFR1 and MET amplifications were restricted to the EGFRwt/KRASwt tumor group, and were mutually exclusive ( MET amplification was borderline non-significant for difference in frequency between mutation groups, p=0.09, Fisher’s exact test).

also in 434 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.